Separation Agreements in the Biotechnology Industry
755 Contracts & Agreements
- 2seventy bio, Inc. (1 contract)
- ABEONA THERAPEUTICS INC. (2)
- ACCELERON PHARMA INC (1)
- Achaogen, Inc. (2)
- ACHIEVE LIFE SCIENCES, INC. (1)
- Acorda Therapeutics (1)
- Actinium Pharmaceuticals, Inc. (2)
- Adagio Therapeutics, Inc. (1)
- Adamas Pharmaceuticals Inc (1)
- ADiTx Therapeutics, Inc. (3)
- ADMA BIOLOGICS, INC. (1)
- ADURO BIOTECH, INC. (5)
- Advaxis, Inc. (3)
- Adverum Biotechnologies, Inc. (11)
- AGENUS INC (1)
- AgeX Therapeutics, Inc. (2)
- AGIOS PHARMACEUTICALS INC (1)
- AILERON THERAPEUTICS INC (2)
- Aimmune Therapeutics, Inc. (3)
- AKCEA THERAPEUTICS, INC. (5)
- Akebia Therapeutics, Inc. (3)
- Akouos, Inc. (1)
- ALBIREO PHARMA, INC. (2)
- Alector, Inc. (1)
- Alexion Pharmaceuticals (3)
- Aligos Therapeutics, Inc. (1)
- Alkermes plc. (2)
- Allakos Inc. (2)
- Allarity Therapeutics, Inc. (2)
- Alliqua BioMedical, Inc. (3)
- Alpha Healthcare Acquisition Corp. (1)
- ALPINE IMMUNE SCIENCES, INC. (4)
- Altimmune, Inc. (4)
- AMARIN CORP PLC (3)
- AMICUS THERAPEUTICS, INC. (1)
- AmpliPhi Biosciences Corp (3)
- Amplitude Healthcare Acquisition Corp (1)
- ANAPTYSBIO INC (1)
- Anika Therapeutics (1)
- Annovis Bio, Inc. (1)
- Applied Molecular Transport Inc. (3)
- Applied Therapeutics Inc. (1)
- Aprea Therapeutics, Inc. (4)
- Aptevo Therapeutics Inc. (1)
- AQUINOX PHARMACEUTICALS, INC (5)
- Aravive, Inc. (8)
- Arbutus Biopharma Corp (3)
- Arcus Biosciences, Inc. (1)
- ARDELYX, INC. (4)
- ARENA PHARMACEUTICALS INC (1)
- Artiva Biotherapeutics, Inc. (1)
- ARYA Sciences Acquisition Corp II (1)
- ASSEMBLY BIOSCIENCES, INC. (2)
- Atara Biotherapeutics, Inc. (1)
- ATHERSYS, INC (1)
- ATOSSA GENETICS INC (1)
- aTYR PHARMA INC (2)
- Aurinia Pharmaceuticals Inc. (4)
- AVEO PHARMACEUTICALS INC (3)
- Avid Bioservices, Inc. (1)
- AVROBIO, Inc. (3)
- Axcella Health Inc. (2)
- Axovant Sciences Ltd. (5)
- AZIYO BIOLOGICS, INC. (1)
- BeiGene, Ltd. (1)
- BELLICUM PHARMACEUTICALS, INC (2)
- BIOCRYST PHARMACEUTICALS INC (1)
- Biogen Inc. (2)
- Biohaven Pharmaceutical Holding Co Ltd. (1)
- BIOMARIN PHARMACEUTICAL INC (2)
- Biomea Fusion, Inc. (1)
- BIOSPECIFICS TECHNOLOGIES CORP (2)
- Biostage, Inc. (4)
- BIOTIME INC (3)
- BioXcel Therapeutics, Inc. (5)
- Black Diamond Therapeutics, Inc. (1)
- Blue Water Vaccines Inc. (1)
- bluebird bio, Inc. (3)
- BRAINSTORM CELL THERAPEUTICS INC. (2)
- CALADRIUS BIOSCIENCES, INC. (1)
- Calyxt, Inc. (5)
- CANCER GENETICS, INC (1)
- CAPRICOR THERAPEUTICS, INC. (2)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
- Capstone Therapeutics Corp. (1)
- CareDx, Inc. (2)
- Caribou Biosciences, Inc. (1)
- CASI Pharmaceuticals, Inc. (1)
- CASTLE BIOSCIENCES INC (2)
- Castle Creek Biosciences, Inc. (1)
- CATALYST BIOSCIENCES, INC. (5)
- CATALYST PHARMACEUTICALS, INC. (2)
- Celldex Therapeutics, Inc. (1)
- Celsion CORP (3)
- Century Therapeutics, Inc. (2)
- Checkmate Pharmaceuticals, Inc. (1)
- Coherus BioSciences, Inc. (1)
- Comera Life Sciences Holdings, Inc. (1)
- COMPASS Pathways plc (1)
- Consonance-HFW Acquisition Corp. (1)
- Constellation Alpha Capital Corp. (2)
- CONTRAFECT Corp (3)
- Corbus Pharmaceuticals Holdings, Inc. (3)
- Cortexyme, Inc. (6)
- CTI BIOPHARMA CORP (3)
- Cullinan Oncology, LLC (1)
- CURIS INC (1)
- Cyclacel Pharmaceuticals, Inc. (2)
- Cyclerion Therapeutics, Inc. (3)
- CytoDyn Inc. (4)
- CytomX Therapeutics, Inc. (8)
- CYTORI THERAPEUTICS, INC. (1)
- CYTRX CORP (1)
- DBV Technologies S.A. (1)
- DelMar Pharmaceuticals, Inc. (1)
- Dermavant Sciences Ltd (1)
- Design Therapeutics, Inc. (1)
- DiaMedica Therapeutics Inc. (2)
- Dicerna Pharmaceuticals Inc (1)
- Diffusion Pharmaceuticals Inc. (8)
- Dyne Therapeutics, Inc. (1)
- Eagle Pharmaceuticals, Inc. (4)
- Edge Therapeutics, Inc. (1)
- Editas Medicine, Inc. (3)
- Eiger BioPharmaceuticals, Inc. (12)
- Elevation Oncology, Inc. (1)
- Emerald Bioscience, Inc. (3)
- Emergent BioSolutions Inc. (1)
- Entera Bio Ltd. (2)
- ENZON PHARMACEUTICALS, INC. (2)
- Equillium, Inc. (1)
- EXACT SCIENCES CORP (1)
- Exelixis (1)
- EXICURE, INC. (8)
- FENNEC PHARMACEUTICALS INC. (2)
- Fibrocell Science, Inc. (6)
- FIVE PRIME THERAPEUTICS INC (1)
- Flex Pharma, Inc. (3)
- Flexion Therapeutics Inc (1)
- Forma Therapeutics Holdings, Inc., (1)
- Fortress Biotech, Inc. (2)
- Frequency Therapeutics, Inc. (4)
- FS Development Corp. (3)
- FS Development Corp. II (2)
- G1 Therapeutics, Inc. (1)
- Gain Therapeutics, Inc. (1)
- GALECTIN THERAPEUTICS INC (2)
- Galecto Inc. (1)
- Galera Therapeutics, Inc. (1)
- Gemphire Therapeutics Inc. (5)
- GENOCEA BIOSCIENCES, INC. (1)
- Genprex, Inc. (1)
- GERON CORP (2)
- Gilead Sciences (1)
- Grail, Inc. (1)
- Graphite Bio, Inc. (1)
- Gritstone Oncology, Inc. (1)
- GTX INC (2)
- HALOZYME THERAPEUTICS INC (1)
- Health Sciences Acquisitions Corp (2)
- HEAT BIOLOGICS, INC. (1)
- HERON THERAPEUTICS, INC. (1)
- HISTOGENICS CORP (4)
- iBio, Inc. (2)
- IDEAYA Biosciences, Inc. (1)
- IDERA PHARMACEUTICALS, INC. (6)
- Imago BioSciences, Inc. (2)
- IMMUNE PHARMACEUTICALS INC (2)
- Immune Therapeutics, Inc. (1)
- Immuneering Corp (1)
- IMMUNOGEN INC (1)
- Immunome Inc. (4)
- IMMUNOMEDICS INC (2)
- Incyte (1)
- Inhibrx, Inc. (2)
- INOVIO PHARMACEUTICALS, INC. (2)
- Inozyme Pharma, Inc. (2)
- INSMED Inc (2)
- Inspyr Therapeutics, Inc. (1)
- Instil Bio, Inc. (1)
- INTERCEPT PHARMACEUTICALS, INC. (1)
- Invitae Corp (1)
- IONIS PHARMACEUTICALS INC (1)
- IRONWOOD PHARMACEUTICALS INC (2)
- Isoray, Inc. (6)
- Kadmon Holdings, Inc. (2)
- KalVista Pharmaceuticals, Inc. (4)
- Karyopharm Therapeutics Inc. (1)
- KBL MERGER CORP. IV (2)
- Keros Therapeutics, Inc. (1)
- Kezar Life Sciences, Inc. (2)
- Kiniksa Pharmaceuticals, Ltd. (1)
- Kiromic Biopharma, Inc. (2)
- Kronos Bio, Inc. (2)
- Kura Oncology, Inc. (3)
- LA JOLLA PHARMACEUTICAL CO (3)
- LianBio (2)
- Ligand Pharmaceuticals Incorporated (4)
- LONGEVERON LLC (2)
- Lyell Immunopharma, Inc. (2)
- Magenta Therapeutics, Inc. (4)
- MARIZYME INC (1)
- Marker Therapeutics, Inc. (1)
- MATEON THERAPEUTICS INC (9)
- Matinas BioPharma Holdings, Inc. (4)
- MAXCYTE, INC. (1)
- MEDICINOVA INC (3)
- MEI Pharma, Inc. (1)
- MeiraGTx Holdings plc (2)
- MERRIMACK PHARMACEUTICALS INC (10)
- Mersana Therapeutics, Inc. (1)
- Metacrine, Inc. (1)
- Millendo Therapeutics, Inc. (5)
- MiMedx Group, Inc. (4)
- MIRAGEN THERAPEUTICS, INC. (4)
- Mirati Therapeutics, Inc. (5)
- Moderna, Inc. (3)
- Moleculin Biotech, Inc. (1)
- Momenta Pharmaceuticals, Inc. (3)
- Monte Rosa Therapeutics, Inc. (1)
- Myovant Sciences Ltd. (2)
- Myriad Genetics, Inc. (3)
- NANOVIRICIDES, INC. (1)
- NAVIDEA BIOPHARMACEUTICALS, INC. (3)
- NEUROTROPE BIOSCIENCE, INC. (3)
- Neurotrope, Inc. (5)
- NEWLINK GENETICS CORP (5)
- NexImmune, Inc. (1)
- Nkarta, Inc. (1)
- NTN BUZZTIME INC (8)
- Ohr Pharmaceutical Inc (2)
- Olema Pharmaceuticals, Inc. (2)
- OncBioMune Pharmaceuticals, Inc (1)
- OncoCyte Corp (4)
- ONCOSEC MEDICAL Inc (4)
- OPGEN INC (1)
- Ophthotech Corp. (2)
- Opko Health, Inc. (2)
- Orchard Therapeutics plc (1)
- Organicell Regenerative Medicine, Inc. (1)
- Organogenesis Holdings Inc. (3)
- ORGANOVO HOLDINGS, INC. (4)
- Outlook Therapeutics, Inc. (3)
- Passage BIO, Inc. (5)
- PDL BIOPHARMA, INC. (5)
- Pfenex Inc. (3)
- Phio Pharmaceuticals Corp. (1)
- PIERIS PHARMACEUTICALS, INC. (2)
- PMV Pharmaceuticals, Inc. (1)
- POLARITYTE, INC. (3)
- Praxis Precision Medicines, Inc. (1)
- PRECISION BIOSCIENCES INC (1)
- Prelude Therapeutics Inc (1)
- PROGENITY, INC. (1)
- Protagonist Therapeutics, Inc (1)
- PROTEON THERAPEUTICS INC (5)
- PROTEOSTASIS THERAPEUTICS, INC. (8)
- Prothena Corp plc (1)
- PTC THERAPEUTICS, INC. (1)
- Radius Health, Inc. (5)
- REGENXBIO Inc. (1)
- RenovaCare, Inc. (1)
- Repare Therapeutics Inc. (1)
- Replimune Group, Inc. (4)
- Retrophin, Inc. (1)
- REXAHN PHARMACEUTICALS, INC. (3)
- RHYTHM PHARMACEUTICALS, INC. (2)
- RIGEL PHARMACEUTICALS INC (1)
- RITTER PHARMACEUTICALS INC (1)
- Rubius Therapeutics, Inc. (1)
- Sage Therapeutics, Inc. (2)
- SANGAMO THERAPEUTICS, INC (1)
- Sarepta Therapeutics, Inc. (7)
- Savara Inc (6)
- Scholar Rock Holding Corp (2)
- SELECTA BIOSCIENCES INC (2)
- SELLAS Life Sciences Group, Inc. (3)
- Sensei Biotherapeutics, Inc. (1)
- SERA PROGNOSTICS, INC. (1)
- Seres Therapeutics, Inc. (2)
- Sesen Bio, Inc. (2)
- Sierra Oncology, Inc. (2)
- Social Capital Suvretta Holdings Corp. III (2)
- Solid Biosciences Inc. (3)
- SOLIGENIX, INC. (2)
- Spectrum Pharmaceuticals, Inc. (1)
- Spero Therapeutics, Inc. (4)
- SPRUCE BIOSCIENCES, INC. (4)
- SQZ Biotechnologies Co (3)
- SUNESIS PHARMACEUTICALS INC (1)
- Surface Oncology, Inc. (1)
- SYNLOGIC, INC. (8)
- Synthetic Biologics, Inc. (3)
- Syros Pharmaceuticals, Inc. (1)
- T2 Biosystems, Inc. (2)
- TENAX THERAPEUTICS, INC. (4)
- TG THERAPEUTICS, INC. (1)
- Transcode Therapeutics, Inc. (2)
- Translate Bio, Inc. (1)
- Trovagene, Inc. (1)
- TScan Therapeutics, Inc. (1)
- TYME TECHNOLOGIES, INC. (1)
- Ultragenyx Pharmaceutical Inc. (1)
- uniQure N.V. (3)
- Unity Biotechnology, Inc. (1)
- Unum Therapeutics Inc. (1)
- UroGen Pharma Ltd. (4)
- VACCINEX, INC. (1)
- Vaxart, Inc. (2)
- Vaxcyte, Inc. (1)
- Vera Therapeutics, Inc. (2)
- VERACYTE, INC. (3)
- Verastem, Inc. (1)
- Vertex Pharmaceuticals Inc (1)
- VICAL INC (5)
- Vir Biotechnology, Inc. (1)
- VITRO DIAGNOSTICS INC (1)
- Vor Biopharma Inc. (1)
- Voyager Therapeutics, Inc. (4)
- vTv Therapeutics Inc. (1)
- WINDTREE THERAPEUTICS INC (4)
- Xencor Inc (2)
- Xilio Therapeutics, Inc. (1)
- XOMA Corp (1)
- Y-mAbs Therapeutics, Inc. (1)
- YIELD10 BIOSCIENCE, INC. (1)
- ZIOPHARM ONCOLOGY INC (4)
- Zymeworks Inc. (2)
- Separation Agreement effective October 3, 2023, by and between the Registrant and Purnanand D. Sarma, Ph.D (Immunome Inc., Filed With SEC on March 28, 2024)
- Separation Agreement effective October 2, 2023, by and between the Registrant and Dennis Giesing (Immunome Inc., Filed With SEC on March 28, 2024)
- Separation Agreement, effective as of March 27, 2024, by and between the Registrant and Barbara Wood (SELLAS Life Sciences Group, Inc., Filed With SEC on March 28, 2024)
- Separation Agreement, effective as of March 26, 2024, by and between the Registrant and Robert Francomano (SELLAS Life Sciences Group, Inc., Filed With SEC on March 28, 2024)
- Separation Agreement by and between the Registrant and Celia Lin, M.D., dated January 3, 2024 (Vera Therapeutics, Inc., Filed With SEC on March 27, 2024)
- Separation Agreement, dated October 16, 2023, by and between the Registrant and Eric. R. Olson, Ph.D (Syros Pharmaceuticals, Inc., Filed With SEC on March 27, 2024)
- Separation Agreement, dated March 25, 2024, between the Company and Joshua Brumm (Dyne Therapeutics, Inc., Filed With SEC on March 25, 2024)
- Transition and Separation Agreement, dated as of November 27, 2023, by and between Disc Medicine, Inc. and Joanne Bryce (FS Development Corp., Filed With SEC on March 21, 2024)
- Separation Agreement, by and between the registrant and Barbara Kosacz, dated January 24, 2024 (Kronos Bio, Inc., Filed With SEC on March 21, 2024)
- Separation Agreement, by and between the registrant and Jorge DiMartino, M.D., Ph.D., dated January 24, 2024 (Kronos Bio, Inc., Filed With SEC on March 21, 2024)
- Separation Agreement, dated September 11, 2023, by and between Magenta Therapeutics, Inc. and Thomas Beetham (Magenta Therapeutics, Inc., Filed With SEC on March 21, 2024)
- Separation Agreement, dated May 12, 2023, by and between Magenta Therapeutics, Inc. and Lisa Olson (Magenta Therapeutics, Inc., Filed With SEC on March 21, 2024)
- Separation Agreement, dated February 7, 2023, by and between Magenta Therapeutics, Inc. and Jason Gardner (Magenta Therapeutics, Inc., Filed With SEC on March 21, 2024)
- Separation Agreement by and between Synlogic, Inc. and Antoine Awad, dated as of February 17, 2024 (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
- Separation Agreement by and between Synlogic, Inc. and Michael Jensen, dated as of November 13, 2023 (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
- Separation Agreement by and between Synlogic, Inc. and Aoife M. Brennan, MB, BCh, BAO, MMSc, dated as of February 17, 2024 (SYNLOGIC, INC., Filed With SEC on March 19, 2024)
- Separation Agreement, dated March 13, 2024, by and between ProKidney, LLC and Deepak Jain, Ph.D (Social Capital Suvretta Holdings Corp. III, Filed With SEC on March 18, 2024)
- Separation Agreement, dated March 13, 2024, by and between ProKidney, LLC and Tim Bertram, Ph.D (Social Capital Suvretta Holdings Corp. III, Filed With SEC on March 18, 2024)
- Separation Agreement, dated February 9, 2024, by and between the Registrant and Tamara Joseph (Spero Therapeutics, Inc., Filed With SEC on March 13, 2024)
- Separation and release agreement with Leonid Beigelman (Aligos Therapeutics, Inc., Filed With SEC on March 12, 2024)
- Separation Letter, dated December 19, 2023, between the Registrant and Syed Rizvi, M.D (Caribou Biosciences, Inc., Filed With SEC on March 11, 2024)
- Separation Agreement dated March 8, 2024 (Eagle Pharmaceuticals, Inc., Filed With SEC on March 8, 2024)
- English Summary Translation of Separation Agreement and Release between Sbastien Robitaille and registrant (DBV Technologies S.A., Filed With SEC on March 7, 2024)
- Separation and Release Agreement, dated effective as of July 7, 2023, between Arbutus Biopharma Corporation and Elizabeth A. Howard (Arbutus Biopharma Corp, Filed With SEC on March 5, 2024)
- Separation Agreement, dated January 5, 2024, by and between the Registrant and Leila Alland, M.D (PMV Pharmaceuticals, Inc., Filed With SEC on February 29, 2024)
- Separation Agreement, dated (Constellation Alpha Capital Corp., Filed With SEC on February 29, 2024)
- Separation Agreement by and between Kineta, Inc. and Pauline Kenny, dated March 1, 2024 (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on February 29, 2024)
- Separation Agreement by and between Kineta, Inc. and Shawn Iadonato, Ph.D., dated March 1, 2024 (PROTEOSTASIS THERAPEUTICS, INC., Filed With SEC on February 29, 2024)
- Separation Agreement between the Company and Alicia Grande (CATALYST PHARMACEUTICALS, INC., Filed With SEC on February 28, 2024)
- Separation Agreement between the Company and Patrick J. McEnany (CATALYST PHARMACEUTICALS, INC., Filed With SEC on February 28, 2024)
- Separation Agreement, dated November 1, 2023, by and between CareDx, Inc. and Reginald Seeto, MBSS (CareDx, Inc., Filed With SEC on February 28, 2024)
- Separation Agreement and General Release, effective March 31, 2023 between Longeveron Inc. and K. Chris Min, M.D. and Ph.D (LONGEVERON LLC, Filed With SEC on February 27, 2024)
- Separation Agreement and General Release, effective June 9, 2023, by and between Longeveron, Inc. and James Clavijo (LONGEVERON LLC, Filed With SEC on February 27, 2024)
- Executive Separation (Moderna, Inc., Filed With SEC on February 23, 2024)
- Separation and Release Agreement, dated February 20, 2024, by and between Salarius Pharmaceuticals, Inc. and David J. Arthur (Flex Pharma, Inc., Filed With SEC on February 23, 2024)
- Separation Agreement, dated January 31, 2024, by and between Vaxart, Inc. and Andrei Floroiu (Vaxart, Inc., Filed With SEC on February 2, 2024)
- Separation and Distribution Agreement, dated as of January 22, 2024, by and among Inhibrx, Inc., Ibex SpinCo, Inc., and Aventis Inc (Inhibrx, Inc., Filed With SEC on January 23, 2024)
- Separation Agreement, dated January 17, 2024, between the Company and Erin Henderson (Blue Water Vaccines Inc., Filed With SEC on January 19, 2024)
- Separation Agreement, dated as of January 10, 2024 by and Between TransCode Therapeutics, Inc. and Robert Michael Dudley (Transcode Therapeutics, Inc., Filed With SEC on January 17, 2024)
- Separation Agreement and Release by and between Rudy C. Howard and Aravive, Inc., dated January 17, 2024 (Aravive, Inc., Filed With SEC on January 17, 2024)